comparemela.com
Home
Live Updates
Hutchmed Sovleplenib accepted for review by China drug bureau : comparemela.com
Hutchmed Sovleplenib accepted for review by China drug bureau
Hutchmed Ltd on Thursday said that its novel treatment for haematological malignancies and immune diseases had been progressed to the next stage of approval by the country's national bureau for drug...
Related Keywords
China ,
Weiguo Su ,
Hugh Cameron ,
Hutchmed Ltd On ,
Alliance News ,
China National Medical Products Administration ,
Alliance News Ltd ,
Hong Kong Based ,
China National Medical Products ,
Executive Officer ,
All Rights ,
Markets ,
comparemela.com © 2020. All Rights Reserved.